Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) EPS (Basic) (2019 - 2025)

Historic EPS (Basic) for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to $0.88.

  • Harmony Biosciences Holdings' EPS (Basic) rose 864.2% to $0.88 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.23, marking a year-over-year increase of 5023.26%. This contributed to the annual value of $2.07 for FY2024, which is 481.88% down from last year.
  • Harmony Biosciences Holdings' EPS (Basic) amounted to $0.88 in Q3 2025, which was up 864.2% from $0.69 recorded in Q2 2025.
  • Harmony Biosciences Holdings' EPS (Basic)'s 5-year high stood at $1.48 during Q3 2022, with a 5-year trough of -$0.17 in Q3 2021.
  • For the 5-year period, Harmony Biosciences Holdings' EPS (Basic) averaged around $0.54, with its median value being $0.49 (2023).
  • In the last 5 years, Harmony Biosciences Holdings' EPS (Basic) tumbled by 7664.67% in 2021 and then surged by 97058.82% in 2022.
  • Quarter analysis of 5 years shows Harmony Biosciences Holdings' EPS (Basic) stood at $0.39 in 2021, then soared by 110.26% to $0.82 in 2022, then plummeted by 43.9% to $0.46 in 2023, then dropped by 17.93% to $0.38 in 2024, then soared by 133.1% to $0.88 in 2025.
  • Its EPS (Basic) stands at $0.88 for Q3 2025, versus $0.69 for Q2 2025 and $0.79 for Q1 2025.